89bio Analyst Ratings
BenzingaApr 22 06:11 ET
89bio Analyst Ratings
BenzingaApr 5 09:21 ET
Buy Rating Affirmed for 89bio's Pegozafermin: A Promising NASH Treatment With Strong Regulatory Endorsements
TipRanksMar 29 03:09 ET
89bio Analyst Ratings
BenzingaMar 27 13:51 ET
Analysts Are Bullish on These Healthcare Stocks: 89bio (ETNB), Perspective Therapeutics (CATX)
TipRanksMar 27 12:30 ET
Analysts Are Bullish on These Healthcare Stocks: 89bio (ETNB), Intuitive Surgical (ISRG)
TipRanksMar 15 05:20 ET
Analysts' Top Healthcare Picks: Zymeworks (ZYME), 89bio (ETNB)
TipRanksMar 13 10:00 ET
89bio Analyst Ratings
BenzingaMar 13 09:49 ET
89bio Analyst Ratings
BenzingaMar 7 10:58 ET
Buy Rating Reaffirmed for 89bio With Potential Market Edge in Fibrosis and Metabolic Diseases
TipRanksMar 6 23:19 ET
89bio Analyst Ratings
BenzingaMar 6 13:56 ET
Analysts' Top Healthcare Picks: 89bio (ETNB), UnitedHealth (UNH)
TipRanksMar 4 19:21 ET
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Vicarious Surgical (RBOT) and 89bio (ETNB)
TipRanksMar 4 19:02 ET
89bio Analyst Ratings
BenzingaMar 4 10:13 ET
RBC Capital Sticks to Their Hold Rating for 89bio (ETNB)
TipRanksMar 1 07:27 ET
89bio Analyst Ratings
BenzingaMar 1 07:18 ET
RBC Capital Downgrades 89bio to Sector Perform, Announces $15 Price Target
BenzingaJan 12 07:16 ET
89bio Analyst Ratings
BenzingaJan 12 07:15 ET
BTIG Sticks to Its Buy Rating for 89bio (ETNB)
TipRanksJan 2 09:19 ET
89bio Analyst Ratings
BenzingaDec 20, 2023 12:43 ET
No Data
No Data